← Explorer/Network

Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation

Ma Y, Liu H, Tu-Rapp H +4 more2004Nature ImmunologyJournal Article
10.1038/ni1054PubMed
Immune/InnateMusculoskeletal

Abstract

The nonapoptotic functions of Fas ligation are incompletely characterized. In contrast to expectations, we show here that Fas-deficient mice developed less-severe collagen-induced arthritis than did control mice. Despite having milder arthritis, Fas-deficient mice had more of the critical pro-inflammatory mediator interleukin-1 beta (IL-1 beta) in their joints, suggesting inefficient activation through IL-1 receptor 1 (IL-1R1) when Fas signaling is deficient. In primary human macrophages and macrophages from Fas- or Fas ligand (FasL)-deficient mice, interruption of Fas-FasL signaling suppressed nuclear factor-kappa B activation and cytokine expression induced by IL-1 beta and lipopolysaccharide. This cross-talk was mediated by the Fas-associated death domain through interaction with myeloid differentiation factor 88. These observations document a unique mechanism whereby Fas-FasL interactions enhance activation through the IL-1R1 or Toll-like receptor 4 pathway, which may contribute to the pathogenesis of chronic arthritis.

Key Biomarkers

Fas-FasL signalingIL-1 betaIL-1R1NF-kB activationToll-like receptor 4

Symptom Clusters

Chronic arthritisChronic inflammation

Cited By (1)

  • The family of five: TIR-domain-containing adaptors in Toll-like receptor signallingNature reviews. Immunology · 2007

References (1)

  • Toll-like receptors and innate immunityNature reviews. Immunology · 2001

Related Papers

  • Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177Frontiers in Immunology · 2022 · 2 shared tags
  • A Transcriptomic Fingerprint for Parkinson's Disease Found in Patients with Chronic Inflammatory Response Syndrome: Implications for Diagnosis, Treatment and PreventionMedical Research Archives · 2024 · 2 shared tags
  • Inflammation and osteosarcopeniaElsevier eBooks · 2022 · 2 shared tags
  • A Narrative Review of the Immunomodulatory Effects of Acthar® Gel Beyond Its Steroidogenic PropertiesAdvances in Therapy · 2025 · 2 shared tags
  • Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent PharmaceuticalsMarine Drugs · 2022 · 2 shared tags
  • Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administrationImmunotherapy Advances · 2023 · 2 shared tags